Almotriptan Malate

CAS 154323-57-6 4 current records 1 historicalSmall Molecule

Who holds supplier records for Almotriptan Malate? 4 organisations hold a current record for Almotriptan Malate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Almotriptan Malate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/almotriptan-malate

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    4 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Almotriptan Malate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Almotriptan Malate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Almotriptan Malate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2020-253 - Rev 01
Almotriptan malate, Crystalline form, micronised and non-micronised
Sept 2025—
SMS PHARMACEUTICALS LIMITED HyderabadIN
CEP 2024-417 - Rev 00
Almotriptan malate
Sept 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Almotriptan Malate are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Apotex Pharmachem India Pvt. Ltd.
    India · Inactive DMF 25225 · filed Aug 2011

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Almotriptan Malate is a selective serotonin receptor agonist used to treat acute migraine attacks. It works by stimulating specific serotonin receptors in the brain, resulting in the constriction of dilated blood vessels.

Chemical identity

IUPAC name
N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;2-hydroxybutanedioic acid
Canonical SMILES
CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O
InChIKey
QHATUKWEVNMHRY-UHFFFAOYSA-N
Synonyms
Axert API, almogran, almotriptan d,l-hydrogenmalate, almotriptan maleate, axert, las 31416 d,l-malate acid, las-31416 d,l-malate acid, las-31416-d,l-malate-acid, pnu-180638e

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-1b and Serotonin-1d Receptor Agonist
Mechanism of action
Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists

Therapeutic areas

NeurologyPain Management

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Almotriptan Malate?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Almotriptan Malate: MSN Laboratories Private Limited (India), SMS Pharmaceuticals limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and Orchid Pharma Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Almotriptan Malate Drug Master Files are active?

MSN Laboratories Private Limited (DMF 25327), SMS Pharmaceuticals limited (DMF 18962), MATRIX PHARMACORP PRIVATE LTD (DMF 20424) and Orchid Pharma Limited (DMF 26177). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Almotriptan Malate records mean?

1 organisation has only inactive Type II DMFs for Almotriptan Malate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Almotriptan Malate have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Almotriptan Malate on the EDQM register, including MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN) and SMS PHARMACEUTICALS LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Almotriptan Malate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Almotriptan Malate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.